"Disease-Free Survival" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Period after successful treatment in which there is no appearance of the symptoms or effects of the disease.
| Descriptor ID |
D018572
|
| MeSH Number(s) |
E01.789.200 E05.318.740.998.300 N05.715.360.750.795.300 N06.850.520.830.998.300
|
| Concept/Terms |
Disease-Free Survival- Disease-Free Survival
- Disease Free Survival
- Event-Free Survival
- Event Free Survival
- Event-Free Survivals
- Survival, Event-Free
- Survivals, Event-Free
- Survival, Disease-Free
- Disease-Free Survivals
- Survival, Disease Free
- Survivals, Disease-Free
Progression-Free Survival- Progression-Free Survival
- Progression Free Survival
- Progression-Free Survivals
- Survival, Progression-Free
- Survivals, Progression-Free
|
Below are MeSH descriptors whose meaning is more general than "Disease-Free Survival".
Below are MeSH descriptors whose meaning is more specific than "Disease-Free Survival".
This graph shows the total number of publications written about "Disease-Free Survival" by people in this website by year, and whether "Disease-Free Survival" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 3 | 3 |
| 1996 | 0 | 7 | 7 |
| 1997 | 0 | 7 | 7 |
| 1998 | 0 | 11 | 11 |
| 1999 | 0 | 8 | 8 |
| 2000 | 0 | 11 | 11 |
| 2001 | 0 | 16 | 16 |
| 2002 | 0 | 6 | 6 |
| 2003 | 0 | 16 | 16 |
| 2004 | 0 | 21 | 21 |
| 2005 | 0 | 13 | 13 |
| 2006 | 0 | 18 | 18 |
| 2007 | 0 | 17 | 17 |
| 2008 | 0 | 26 | 26 |
| 2009 | 0 | 25 | 25 |
| 2010 | 0 | 23 | 23 |
| 2011 | 0 | 34 | 34 |
| 2012 | 1 | 29 | 30 |
| 2013 | 0 | 37 | 37 |
| 2014 | 0 | 47 | 47 |
| 2015 | 0 | 51 | 51 |
| 2016 | 0 | 52 | 52 |
| 2017 | 0 | 52 | 52 |
| 2018 | 0 | 39 | 39 |
| 2019 | 0 | 26 | 26 |
| 2020 | 0 | 24 | 24 |
| 2021 | 0 | 9 | 9 |
| 2022 | 0 | 7 | 7 |
| 2023 | 0 | 7 | 7 |
| 2024 | 0 | 11 | 11 |
To return to the timeline,
click here.
Below are the most recent publications written about "Disease-Free Survival" by people in Profiles.
-
Long-term survival can be achieved in a significant fraction of older patients with core-binding factor acute myeloid leukemia treated with intensive chemotherapy. Haematologica. 2025 Mar 01; 110(3):608-620.
-
Adjuvant Dose-Dense Chemotherapy in Hormone Receptor-Positive Breast Cancer. J Clin Oncol. 2025 Apr; 43(10):1229-1239.
-
Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children. N Engl J Med. 2025 Feb 27; 392(9):875-891.
-
Laparoscopy-assisted versus open surgery for low rectal cancer (LASRE): 3-year survival outcomes of a multicentre, randomised, controlled, non-inferiority trial. Lancet Gastroenterol Hepatol. 2025 Jan; 10(1):34-43.
-
Disease-free survival as surrogate for overall survival in real-world settings for esophageal cancer: an analysis of SEER-Medicare data. ESMO Open. 2024 Nov; 9(11):103934.
-
Posttreatment surveillance intensity and overall survival in prostate cancer survivors (AFT-30). JNCI Cancer Spectr. 2024 Nov 01; 8(6).
-
Impact of systemic therapy on clinical T1 small-cell neuroendocrine carcinoma of the bladder. ESMO Open. 2024 Nov; 9(11):103964.
-
Outcomes of patients treated with chemotherapy for breast cancer during pregnancy compared with nonpregnant breast cancer patients treated with systemic therapy. Cancer. 2025 Jan 01; 131(1):e35619.
-
Intensification of upfront chemotherapy for patients with myeloid blast phase CML: a single center experience. Ann Hematol. 2024 Dec; 103(12):5395-5403.
-
Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without Radiotherapy for Newly Diagnosed, High-Risk Endometrial Cancer: Results in Mismatch Repair-Deficient Tumors. J Clin Oncol. 2025 Jan 20; 43(3):251-259.